BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12671838)

  • 1. C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients: a 2-year prospective study.
    Chauveau P; Level C; Lasseur C; Bonarek H; Peuchant E; Montaudon D; Vendrely B; Combe C
    J Ren Nutr; 2003 Apr; 13(2):137-43. PubMed ID: 12671838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin: a new marker of inflammation in haemodialysis patients?
    Level C; Chauveau P; Delmas Y; Lasseur C; Pellé G; Peuchant E; Montaudon D; Combe C
    Nephrol Dial Transplant; 2001 May; 16(5):980-6. PubMed ID: 11328904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of procalcitonin levels in comparison to other markers of inflammation in hemodialysis patients.
    Visvardis G; Griveas I; Fleva A; Giannakou A; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Pavlitou K; Sakellariou G
    Ren Fail; 2005; 27(4):429-34. PubMed ID: 16060132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-calcitonin and inflammation in chronic hemodialysis.
    Trimarchi H; Dicugno M; Muryan A; Lombi F; Iturbe L; Raña MS; Young P; Nau K; Iriarte R; Pomeranz V; Forrester M; Karl A; Alonso M
    Medicina (B Aires); 2013; 73(5):411-6. PubMed ID: 24152395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin as a marker of micro-inflammation in hemodialysis.
    Conti G; Amore A; Chiesa M; Mancuso D; Cirina P; Mengozzi G; Santoro A; Coppo R
    J Nephrol; 2005; 18(3):282-8. PubMed ID: 16013016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis.
    Lam MF; Leung JC; Lam CW; Tse KC; Lo WK; Lui SL; Chan TM; Tam S; Lai KN
    Perit Dial Int; 2008; 28(4):377-84. PubMed ID: 18556380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients.
    Meisner M; Adina H; Schmidt J
    Crit Care; 2006 Feb; 10(1):R1. PubMed ID: 16356205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
    Sitter T; Schmidt M; Schneider S; Schiffl H
    J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver.
    Bota DP; Van Nuffelen M; Zakariah AN; Vincent JL
    J Lab Clin Med; 2005 Dec; 146(6):347-51. PubMed ID: 16310518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of procalcitonin and C-reactive protein as markers of sepsis.
    Luzzani A; Polati E; Dorizzi R; Rungatscher A; Pavan R; Merlini A
    Crit Care Med; 2003 Jun; 31(6):1737-41. PubMed ID: 12794413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong correlation of B2-microglobulin (B2-m) with procalcitonin (PCT) in the serum of chronic hemodialysis patients: a role for infections in the dialysis-related amyloidosis?
    Kalocheretis P; Revela I; Spanou E; Drouzas A; Makriniotou I; Iatrou C
    Ren Fail; 2008; 30(3):261-5. PubMed ID: 18350445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin in patients with acute and chronic renal insufficiency.
    Steinbach G; Bölke E; Grünert A; Störck M; Orth K
    Wien Klin Wochenschr; 2004 Dec; 116(24):849-53. PubMed ID: 15690970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of procalcitonin and high sensitivity C-reactive protein are associated with long-term mortality in acute ischemic stroke.
    Li YM; Liu XY
    J Neurol Sci; 2015 May; 352(1-2):68-73. PubMed ID: 25868898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates.
    Claeys R; Vinken S; Spapen H; ver Elst K; Decochez K; Huyghens L; Gorus FK
    Crit Care Med; 2002 Apr; 30(4):757-62. PubMed ID: 11940741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma procalcitonin and the risk of cardiovascular events and death: a prospective population-based study.
    Schiopu A; Hedblad B; Engström G; Struck J; Morgenthaler NG; Melander O
    J Intern Med; 2012 Nov; 272(5):484-91. PubMed ID: 22530956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein.
    Rothenburger M; Markewitz A; Lenz T; Kaulbach HG; Marohl K; Kuhlmann WD; Weinhold C
    Clin Chem Lab Med; 1999 Mar; 37(3):275-9. PubMed ID: 10353472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin versus C-reactive protein and immature-to-total neutrophil ratio as markers of infection after cardiopulmonary bypass in children.
    McMaster P; Park DY; Shann F; Cochrane A; Morris K; Gray J; Cottrell S; Belcher J
    Pediatr Crit Care Med; 2009 Mar; 10(2):217-21. PubMed ID: 19057447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum procalcitonin in pulmonary tuberculosis.
    Rasmussen TA; Søgaard OS; Camara C; Andersen PL; Wejse C
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):251-6, i. PubMed ID: 21219690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.
    Arkader R; Troster EJ; Lopes MR; Júnior RR; Carcillo JA; Leone C; Okay TS
    Arch Dis Child; 2006 Feb; 91(2):117-20. PubMed ID: 16326799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin and mortality in status epilepticus: an observational cohort study.
    Sutter R; Valença M; Tschudin-Sutter S; Rüegg S; Marsch S
    Crit Care; 2015 Oct; 19():361. PubMed ID: 26450065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.